Moderna, Pfizer’s new race: The RSV vaccine FDA approval process

...

Pfizer’s vaccine is already in the FDA approval process and Moderna CEO Stéphane Bancel told CNBC from Davos on Wednesday that it will be filing for FDA approval for its vaccine soon — it even had a plan in place for top executives to be ready to submit over the holidays if needed.

ALSO SEE: Moderna says its RNA vaccine was nearly 84% effective in preventing symptoms in adults 60 and older

...

Pfizer asks FDA to clear updated COVID shot for kids under 5 Pfizer is asking U.S. regulators to authorize its updated COVID-19 vaccine for children under age 5 — not as a booster but part of their initial shots. Children ages 6 months through 4 years already are supposed to get three extra-small doses of the original Pfizer COVID-19 vaccine — each a tenth of the amount adults receive — as their primary series. AP NEWS

...

New study finds increased risk of diabetes after COVID illness Over the pandemic, scientists have learned that the coronavirus can lead to a wide range of ongoing health problems — including diabetes, according to a new study. New research published in the journal BMC Medicine this month sheds light on how patients who have contracted COVID-19 are at greater risk of developing diabetes — both type 1 and type 2. YahooNews

...